---
title: "Regentis Biomaterials Ltd. (RGNT.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/RGNT.US.md"
symbol: "RGNT.US"
name: "Regentis Biomaterials Ltd."
industry: "Biotechnology"
---

# Regentis Biomaterials Ltd. (RGNT.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.regentis.co.il](https://www.regentis.co.il) |

## Company Profile

Regentis Biomaterials Ltd., a regenerative medicine company, develops tissue repair solutions in the United States. The company offers orthopedic treatments using Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Its ...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -63.54 | 547/604 | - | - | - |
| PB | -0.48 | 474/604 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/RGNT.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/RGNT.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/RGNT.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.